The current standard-of-care (SOC) practice for defining the clinical target volume (CTV) for radiation therapy (RT) in patients with glioblastoma still employs an isotropic 1–2 cm expansion of the T2-hyperintensity lesion, without considering the heterogeneous…
Continue Reading
Source: GE Healthcare MR Contour DL
What You Should Know:
– At the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress, GE HealthCare today announced significant advancements in its radiation oncology offerings.
– These include…
Continue Reading
Image by freepik
What You Should Know:
– Researchers at Brigham and Women’s Hospital have leveraged artificial intelligence (AI) to gain a deeper understanding of the risk of specific cardiac arrhythmias in patients undergoing radiation therapy…
Continue Reading
Introduction
The radiotherapy market is experiencing significant growth, driven by an increasing incidence of cancer and advancements in technology. According to a recent analysis by Mordor Intelligence, the market is expected to expand substantially from…
Table of Contents
Introduction
Elekta Evo: An Overview
Key Features of the Elekta Evo
Benefits of Adaptive Radiotherapy
Elekta ONE Planning: A Comprehensive Treatment Planning System
Industry Reception and Future Prospects of Elekta Evo
FAQs
Conclusion
Introduction
The recent unveiling of Elekta Evo, an…
GE HealthCare has partnered with radiation therapy company Elekta to develop new software to improve clinicians experience and enable greater precision treatment. Elekta will use GE HealthCare’s MIM Software imaging management platform, which GE HealthCare…
Continue Reading
GE HealthCare has partnered with radiation therapy company Elekta to develop new software to improve clinicians experience and enable greater precision treatment. Elekta will use GE HealthCare’s MIM Software imaging management platform, which GE HealthCare…
Continue Reading
What You Should Know:
– Just weeks after acquiring MIM Software, a leader in medical imaging analysis and AI solutions, GE HealthCare strengthens its commitment to improving cancer care through a deeper collaboration with Elekta,…
Continue Reading
Delve into the revolutionary impact of DCISionRT in guiding radiation therapy for ductal carcinoma in situ (DCIS) patients. Prelude Corporation unveils groundbreaking data at the ASBrS Annual Meeting, highlighting the integration of molecular insights…
Continue Reading
Varian, a Siemens Healthineers company, has obtained FDA clearance for its TrueBeam and Edge radiotherapy systems featuring the innovative HyperSight imaging solution. This advancement aims to enhance treatment accuracy and minimize damage to healthy…
Continue Reading
